Gene:MYH11: Difference between revisions
| [unchecked revision] | [unchecked revision] |
Brian.Davis (talk | contribs) No edit summary |
Brian.Davis (talk | contribs) |
||
| Line 27: | Line 27: | ||
inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11 | inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11 | ||
Approximately 5-8% of AML cases have inv(16)(p13.1q22) or t(16;16)(p13.1;q22) [1]. | Approximately 5-8% of AML cases have inv(16)(p13.1q22) or t(16;16)(p13.1;q22) [1]. The translocation inv(16)(p13.1q22) or t(16;16)(p13.1;q22) leading to a CBFB-MYH11 fusion gene may be an early event in the development of Acute Myeloid Leukemia (AML) [2]. | ||
==Gene Overview== | ==Gene Overview== | ||